Ocata Therapeutics Inc fka OCAT

[beninsac]

I think the PPS moves are based more on how likely ACTC is to succeed. The new CEO and financing showed us that bankruptcy isn't a concern, and that progression is moving forward. The TLD will hopefully give us an idea of what to expect from the FDA, and move us significantly higher if things look good. The biggest move in my opinion will come next year with breakthrough status from the FDA.